Endosense is a medical device company dedicated to developing, manufacturing and distributing cardiovascular devices for the diagnosis and treatment of various cardiac rhythm disorders. Using motorized robotic catheters capable of navigating inside the cardiovascular system, the novel technology enables physicians to guide and position endovascular catheters at target in a reproducible and precise fashion. This drastically reduces the need for fluoroscopy and greatly improves the precision and speed of the operation. Initially, Endosense will develop three different applications (RoboPace, RoboArt, and RoboScor), but its technology platform opens up opportunities for the development of multiple products for the endovascular device market.